Reported 3 days ago
Pfizer Inc. (PFE) is highlighted as a leading blue chip stock to consider investing in, as it trades near its 52-week low amidst market corrections influenced by economic uncertainties and new trade policies. With operational revenue growth of 12% in its non-COVID products and significant R&D advancements, Pfizer demonstrates strong commercial execution and potential for future growth. Despite current market struggles, underlying fundamentals suggest that Pfizer remains a promising investment opportunity.
Source: YAHOO